281 related articles for article (PubMed ID: 35873373)
21. Perspectives and Prospective on Solid Lipid Nanoparticles as Drug Delivery Systems.
Madkhali OA
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268643
[TBL] [Abstract][Full Text] [Related]
22. Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.
Tapeinos C; Battaglini M; Ciofani G
J Control Release; 2017 Oct; 264():306-332. PubMed ID: 28844756
[TBL] [Abstract][Full Text] [Related]
23. Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil).
D'Souza A; Shegokar R
Curr Drug Deliv; 2021; 18(3):249-270. PubMed ID: 32324512
[TBL] [Abstract][Full Text] [Related]
24. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme.
Jnaidi R; Almeida AJ; Gonçalves LM
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32927610
[TBL] [Abstract][Full Text] [Related]
25. Diethylene glycol monoethyl ether-mediated nanostructured lipid carriers enhance
Zhang H; Guo J; Wang Z; Wang N; Feng N; Zhang Y
Acta Pharm; 2023 Mar; 73(1):133-143. PubMed ID: 36692464
[TBL] [Abstract][Full Text] [Related]
26. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
Wang W; Chen L; Huang X; Shao A
AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
[TBL] [Abstract][Full Text] [Related]
27. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
Chen CC; Tsai TH; Huang ZR; Fang JY
Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticles fabricated from bulk solid lipids: Preparation, properties, and potential food applications.
Zhong Q; Zhang L
Adv Colloid Interface Sci; 2019 Nov; 273():102033. PubMed ID: 31614266
[TBL] [Abstract][Full Text] [Related]
29. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles.
Zhang Y; Li Z; Zhang K; Yang G; Wang Z; Zhao J; Hu R; Feng N
Int J Pharm; 2016 Sep; 511(1):57-64. PubMed ID: 27374194
[TBL] [Abstract][Full Text] [Related]
30. Solid lipid nanoparticles as carriers for lipophilic compounds for applications in foods.
da Silva Santos V; Badan Ribeiro AP; Andrade Santana MH
Food Res Int; 2019 Aug; 122():610-626. PubMed ID: 31229120
[TBL] [Abstract][Full Text] [Related]
31. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
32. An update on the application of nano-scaled carriers against fluconazole-resistant
Moazeni M; Saeedi M; Kelidari H; Nabili M; Davari A
Curr Med Mycol; 2019; 5(4):8-13. PubMed ID: 32104738
[TBL] [Abstract][Full Text] [Related]
33. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis.
Katari O; Jain S
Expert Opin Drug Deliv; 2021 Dec; 18(12):1857-1872. PubMed ID: 34823429
[TBL] [Abstract][Full Text] [Related]
34. Improved Dermal Delivery of Cyclosporine A Loaded in Solid Lipid Nanoparticles.
Essaghraoui A; Belfkira A; Hamdaoui B; Nunes C; Lima SAC; Reis S
Nanomaterials (Basel); 2019 Aug; 9(9):. PubMed ID: 31461853
[TBL] [Abstract][Full Text] [Related]
35. Recent Techniques and Patents on Solid Lipid Nanoparticles as Novel Carrier for Drug Delivery.
Khatak S; Dureja H
Recent Pat Nanotechnol; 2015; 9(3):150-77. PubMed ID: 27009132
[TBL] [Abstract][Full Text] [Related]
36. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
Talegaonkar S; Bhattacharyya A
AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
[TBL] [Abstract][Full Text] [Related]
37. Long-term anesthetic analgesic effects: Comparison of tetracaine loaded polymeric nanoparticles, solid lipid nanoparticles, and nanostructured lipid carriers in vitro and in vivo.
Liu X; Zhao Q
Biomed Pharmacother; 2019 Sep; 117():109057. PubMed ID: 31203133
[TBL] [Abstract][Full Text] [Related]
38. Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers.
Kuo YC; Chung JF
Colloids Surf B Biointerfaces; 2011 Apr; 83(2):299-306. PubMed ID: 21194902
[TBL] [Abstract][Full Text] [Related]
39. Lipid Nanoparticles for Nasal/Intranasal Drug Delivery.
Cunha S; Amaral MH; Lobo JMS; Silva AC
Crit Rev Ther Drug Carrier Syst; 2017; 34(3):257-282. PubMed ID: 28845761
[TBL] [Abstract][Full Text] [Related]
40. Distribution of a model bioactive within solid lipid nanoparticles and nanostructured lipid carriers influences its loading efficiency and oxidative stability.
Pan Y; Tikekar RV; Nitin N
Int J Pharm; 2016 Sep; 511(1):322-330. PubMed ID: 27418566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
